Featured news in The Life Sciences Report



Regeneus Ltd. (RGS:ASX)
Will Receive Key Patent for Progenza from Japanese Patent Office (5/23/2017)

view
 


ProMIS Neurosciences Inc. (PMN:TSX; PMN:NCM)
ProMIS Neurosciences Designates PMN350 its Second Lead Product for Development in Alzheimer’s Disease (5/24/2017)

view
 


Viveve Medical Inc. (VIVE:NASDAQ)
Viveve Secures $30 million Debt Financing with CRG (5/23/2017)

view
 

Viveve Medical Inc. (VIVE:NASDAQ)
Viveve to Participate in the Craig-Hallum Institutional Investor Conference (5/24/2017)

view
 


Inovio Pharmaceuticals Inc. (INO:NASDAQ)
Inovio HIV Vaccine Elicits Nearly 100% Immune Response Rates in a Clinical Study (5/24/2017)

view
 


Celgene Corp. (CELG:NASDAQ)
Celgene (CELG) Multiple Sclerosis Drug Meets Primary Endpoint (5/23/2017)

view
 

Celgene Corp. (CELG:NASDAQ)
Biotech Stock Roundup: FDA Nod for Regeneron RA Drug, Amgen Hit by Study Data (5/24/2017)

view
 

Celgene Corp. (CELG:NASDAQ)
Blog Coverage: Celgene Reported Positive Late Stage Results from Trial of Ozanimod in Patients with Relapsing Multiple Sclerosis (5/24/2017)

view
 


Resverlogix Corp. (RVX:TSX)
Recent Publication and Patent Application Referencing Apabetalone Support its Continued Development and Success (5/23/2017)

view
 


RXi Pharmaceuticals Corp. (PHIO:NASDAQ)
NetworkNewsBreaks - Top 10 Mid-day Percentage Gainers on May 22, 2017 (5/22/2017)

view
 

RXi Pharmaceuticals Corp. (PHIO:NASDAQ)
RXi Pharmaceuticals to Present at the 3rd Annual Immuno-Oncology BD&L and Investment Forum (5/23/2017)

view
 

RXi Pharmaceuticals Corp. (PHIO:NASDAQ)
PCI Biotech and RXi Pharmaceuticals Extend Research Collaboration to the Field of Immuno-oncology (5/22/2017)

view
 


BrainStorm Cell Therapeutics Inc. (BCLI:NASDAQ)
BrainStorm to Present at Cell & Gene Exchange Conference in Washington DC (5/22/2017)

view